Even though SPARC is highly expressed in several tumors, it may be able to inhibit tumorigenesis or tumor progression in human ovarian cancer [38] and its expression is reduced in ovarian cancer cell lines [38]. The gene discussed is SPARC; the disease is ovarian carcinoma.